A novel biologically active seleno-organic compound-V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase

Biochemical Pharmacology

Volumn 34, Issue 15, 1985, Pages 2691-2694

  Safayhi, Hasan ^a   Tiegs, Gisa ^a   Wendel, Albrecht ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; EBSELEN; LEUKOTRIENE; LIPOXYGENASE; NEW DRUG; ORGANOSELENIUM DERIVATIVE; P2 51; UNCLASSIFIED DRUG;

BLOOD AND HEMOPOIETIC SYSTEM; DRUG EFFICACY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NEUTROPHIL; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; RAT;

ANIMAL; ANTI-INFLAMMATORY AGENTS; AZOLES; GLUTATHIONE PEROXIDASE; HYDROXYEICOSATETRAENOIC ACIDS; LEUKOTRIENE B4; LIPOXYGENASE INHIBITORS; NEUTROPHILS; RATS; RATS, INBRED STRAINS; SELENIUM;

EID: 0021814689     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(85)90569-6     Document Type: Article

References (15)

1. A novel biologically active seleno-organic compound—1
2. A novel biologically active selenoorganic compound—IV